Drugs / KPI-012
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05727878 | Feb 2023 → Sep 2025 | corneal disorder | Combangio, Inc | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KPI-012 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05727878 ↗ |